Branaplam

branaplam · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Branaplam, covering 2025-04-09 to 2025-04-09. Get the full timeline:

Most recent: Clinical Trial Update: An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA) [Phase 1, Phase 2]